Tuning solubility and stability of hydrochlorothiazide co-crystals.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Acta Crystallographica. Section B: Structural Science, Crystal Engineering and Materials

• Publication date

  2014-02-01

• Fields of study

  Medicine, Materials Science, Chemistry

• Identifiers
  DOI 10.1107/S2052520613026917PMID 24441131
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Synthon identification in co-crystals and polymorphs with IR spectroscopy. Primary amides as a case study

  2013cited by this paper
• Polymorphs and a Hydrate of Furosemide–Nicotinamide 1:1 Cocrystal

  2012cited by this paper
• Crystal engineering of stable temozolomide cocrystals.

  2012cited by this paper
• Sulfonamide−Pyridine-N-oxide Cocrystals

  2011cited by this paper
• Cocrystals of quercetin with improved solubility and oral bioavailability.

  2011cited by this paper
• Solubility enhancement studies of hydrochlorothiazide by preparing soliddispersions using losartan potassium and urea by different methods

  2011cited by this paper
• Fast Dissolving Curcumin Cocrystals

  2011cited by this paper
• Hydrogen Bonding in Pyridinium Picrates: From Discrete Ion Pairs to 3D Networks

  2011cited by this paper
• Hierarchy of Supramolecular Synthons: Persistent Hydrogen Bonds Between Carboxylates and Weakly Acidic Hydroxyl Moieties in Cocrystals of Zwitterions

  2010cited by this paper
• Structure―Stability Relationships in Cocrystal Hydrates: Does the Promiscuity of Water Make Crystalline Hydrates the Nemesis of Crystal Engineering?

  2010cited by this paper
• Bond lengths in organic and metal-organic compounds revisited: X-H bond lengths from neutron diffraction data.

  2010influential reference
• Using cocrystals to systematically modulate aqueous solubility and melting behavior of an anticancer drug.

  2009influential reference
• Structure validation in chemical crystallography

  2009influential reference
• Solubility Advantage of Pharmaceutical Cocrystals

  2009cited by this paper
• The role of solvent in mechanochemical and sonochemical cocrystal formation: a solubility-based approach for predicting cocrystallisation outcome

  2009cited by this paper
• The Role of π-Stacking in the Composition of Phloroglucinol and Phenazine Cocrystals

  2008cited by this paper
• A short history of SHELX.

  2008influential reference
• Accurate molecular structures of chlorothiazide and hydrochlorothiazide by joint refinement against powder neutron and X-ray diffraction data.

  2008cited by this paper
• Hierarchy of Supramolecular Synthons: Persistent Carboxylic Acid···Pyridine Hydrogen Bonds in Cocrystals That also Contain a Hydroxyl Moiety

  2008cited by this paper
• Celecoxib:nicotinamide dissociation: using excipients to capture the cocrystal's potential.

  2007cited by this paper
• Hydro­chloro­thia­zide N,N-dimethyl­acetamide disolvate

  2006cited by this paper
• Reaction crystallization of pharmaceutical molecular complexes.

  2006cited by this paper
• Hydrochlorothiazide N,N-dimethylformamide solvate

  2006cited by this paper
• Use of a Glutaric Acid Cocrystal to Improve Oral Bioavailability of a Low Solubility API

  2006cited by this paper
• Comparison of a miniaturized shake-flask solubility method with automated potentiometric acid/base titrations and calculated solubilities.

  2005cited by this paper
• Powder study of hydro­chloro­thia­zide–methyl acetate (1/1)

  2005cited by this paper
• Crystal engineering approach to forming cocrystals of amine hydrochlorides with organic acids. Molecular complexes of fluoxetine hydrochloride with benzoic, succinic, and fumaric acids.

  2004cited by this paper
• Crystal engineering of novel cocrystals of a triazole drug with 1,4-dicarboxylic acids.

  2003cited by this paper
• The Cambridge Structural Database: a quarter of a million crystal structures and rising.

  2002cited by this paper
• X-Seed — A Software Tool for Supramolecular Crystallography

  2001influential reference
• Design of a Three Component Crystal Based on the Cocrystal of Phenazine and 2,2′-Dihydroxybiphenyl

  1999cited by this paper
• POWDER CELL– a program for the representation and manipulation of crystal structures and calculation of the resulting X‐ray powder patterns

  1996cited by this paper
• A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability

  1995influential reference
• Selective formation of hydrogen bonded cocrystals between a sulfonamide and aromatic carboxylic acids in the solid state

  1995cited by this paper
• Supramolecular Synthons in Crystal Engineering—A New Organic Synthesis

  1995cited by this paper
• The nature of halogen ⋯ halogen interactions and the crystal structure of 1,3,5,7-tetraiodoadamantane

  1994influential reference
• Pharmaceutical studies on the polymorphism of hydrochlorothiazide

  1984cited by this paper
• Bioavailability of hydrochlorothiazide from tablets and suspensions.

  1984cited by this paper
• On enantiomorph‐polarity estimation

  1983influential reference
• Structure cristalline de l'hydrochlorothiazide, C7H8ClN3O4S2

  1972cited by this paper

• Exploring Chemical Reactivity and Molecular Interactions of Hydrochlorothiazide-Isonicotinamide Cocrystal Hydrate: A Comparative Spectroscopic and Quantum Chemical Study using Hydrochlorothiazide-4-Aminobenzoic Acid Cocrystal

  2026cites this paper
• DESIGN AND CHARACTERIZATION OF GLIBENCLAMIDE-CAFFEIC ACID COCRYSTALS VIA CRYSTAL ENGINEERING

  2025cites this paper
• Mechanochemical synthesis of hydrochlorothiazide-nicotinamide cocrystal: from batch-based ball-milling to scale-up ready hot melt extrusion.

  2025cites this paper
• The Vortex-Slurry Implementation: A Cheap, Easy, and Ultrafast Mechanochemical Tool to Synthesize/Screen Pharmaceutical Salts and Cocrystals

  2025influential citation
• Enhancement of Lurasidone Hydrochloride Dissolution and Pharmacodynamic Properties Via Co-crystal and Eutectic Formation

  2025cites this paper
• The 1:1 gallic acid-N-methylurea cocrystal: QTAIM and NBO studies of the O-H...O and N-H...O hydrogen-bonded supramolecular carboxylic acid-urea heterosynthon.

  2025cites this paper
• Study of chemical reactivity and molecular interactions of the hydrochlorothiazide-4-aminobenzoic acid cocrystal using spectroscopic and quantum chemical approaches.

  2024cites this paper
• Amide bioisosteric replacement in the design and synthesis of quorum sensing modulators.

  2024cites this paper
• A Perspective on the Permeability of Cocrystals/Organic Salts of Oral Drugs.

  2024cites this paper
• Bioanalytical methods and extraction techniques for the quantification of hydrochlorothiazide and its pharmaceutical combinations: A comprehensive review

  2024cites this paper
• Influence of formulation variables on the processability and properties of tablets manufactured by fused deposition modelling.

  2023cites this paper
• Atorvastatin ascorbic acid cocrystal strategy to improve the safety and efficacy of atorvastatin

  2022cites this paper
• Feasibility of high melting point hydrochlorothiazide processing via cocrystal formation by hot melt extrusion paired fused filament fabrication as a 3D-printed cocrystal tablet.

  2022cites this paper
• Towards the Development of Novel Diclofenac Multicomponent Pharmaceutical Solids

  2022cites this paper
• Adjusting the melting point of an Active Pharmaceutical Ingredient (API) via cocrystal formation enables processing of high melting drugs via combined hot melt and materials extrusion (HME and ME)

  2022cites this paper
• Synthesis, Characterization, and Intrinsic Dissolution Studies of Drug–Drug Eutectic Solid Forms of Metformin Hydrochloride and Thiazide Diuretics

  2021cites this paper
• Determination of co-crystal phase purity by mid infrared spectroscopy and multiple curve resolution.

  2021cites this paper
• Formation of Hydrochlorothiazide – Para-aminobenzoic Acid Cocrystals by Solvent Evaporation Method

  2021cites this paper
• In-silico methods of cocrystal screening: A review on tools for rational design of pharmaceutical cocrystals

  2021cites this paper
• A norfloxacin-nicotinic acid cocrystal: Mechanochemical synthesis, thermal and structural characterization and solubility assays

  2020cites this paper
• Sacubitril-valsartan cocrystal revisited: role of polymer excipients in the formulation

  2020cites this paper
• Interconvertible Hydrochlorothiazide–Caffeine Multicomponent Pharmaceutical Materials: A Solvent Issue

  2020influential citation
• Sustainable synthesis of ambrisentan – syringic acid cocrystal: employing mechanochemistry in the development of novel pharmaceutical solid form

  2020cites this paper
• Dissolution and permeability properties of co-amorphous formulations of hydrochlorothiazide.

  2020cites this paper
• A new salt of clofazimine to improve leprosy treatment

  2020cites this paper
• Influence of Excipients on Cocrystal Stability and Formation

  2020cites this paper
• Drug-drug cocrystals: Opportunities and challenges

  2020cites this paper
• Lower melting pharmaceutical cocrystals of metaxalone with carboxamide functionalities

  2019cites this paper
• Investigation of an Unusual Crystal Habit of Hydrochlorothiazide Reveals Large Polar Enantiopure Domains and a Possible Crystal Nucleation Mechanism.

  2019cites this paper
• Supramolecular synthon hierarchy in sulfonamide cocrystals with syn-amides and N-oxides

  2019cites this paper
• An overview of techniques for multifold enhancement in solubility of poorly soluble drugs

  2019cites this paper
• Enhancing the bioavailability of active pharmaceutical ingredients through cocrystallization and coamorphization

  2019cites this paper
• Discriminatory Dissolution Testing for Liquisolid Compacts Containing a Poorly Water-Soluble Drug (Hydrochlorothiazide)

  2019cites this paper
• Investigating the application of FDM 3D printing pattern in preparation of patient-tailored dosage forms

  2019cites this paper
• Considerations on high-throughput cocrystals screening by ultrasound assisted cocrystallization and vibrational spectroscopy.

  2019cites this paper
• Challenges in Transitioning Cocrystals from Bench to Bedside: Dissociation in Prototype Drug Product Environment.

  2018cites this paper
• Xylitol as a potential co-crystal co-former for enhancing dissolution rate of felodipine: preparation and evaluation of sublingual tablets

  2018cites this paper
• Vibrational Spectroscopy for Cocrystals Screening. A Comparative Study

  2018cites this paper
• Channelled tablets: An innovative approach to accelerating drug release from 3D printed tablets

  2018cites this paper
• New Cocrystals of Hydrochlorothiazide: Optimizing Solubility and Membrane Diffusivity

  2017cites this paper
• Antioxidant-Based Eutectics of Irbesartan: Viable Multicomponent Forms for the Management of Hypertension

  2017cites this paper
• Mitigating Cocrystal Physical Stability Liabilities in Preclinical Formulations.

  2017cites this paper
• Pharmaceutical Cocrystal of Piroxicam: Design, Formulation and Evaluation

  2017cites this paper
• Facile formation of co-amorphous atenolol and hydrochlorothiazide mixtures via cryogenic-milling: Enhanced physical stability, dissolution and pharmacokinetic profile.

  2017cites this paper
• BCS class IV drugs: Highly notorious candidates for formulation development

  2017cites this paper
• Statistical process control of cocrystallization processes: A comparison between OPLS and PLS.

  2017influential citation
• A Comprehensive Cocrystal Screening Study of Chlorothiazide

  2017cites this paper
• Three new hydrochlorothiazide cocrystals: Structural analyses and solubility studies

  2017cites this paper
• Co-crystallization for enhanced dissolution rate of nateglinide: In vitro and in vivo evaluation

  2017cites this paper
• Drug-Drug Multicomponent Solid Forms: Cocrystal, Coamorphous and Eutectic of Three Poorly Soluble Antihypertensive Drugs Using Mechanochemical Approach

  2017cites this paper
• Adducts of N-Heterocyclic Drugs, Niacin, Allopurinol, and Amiloride, with 2,4-Pyridinedicarboxylic Acid Coformer

  2017cites this paper
• Sucralose as co-crystal co-former for hydrochlorothiazide: development of oral disintegrating tablets

  2016cites this paper
• Specific energy contributions from competing hydrogen-bonded structures in six polymorphs of phenobarbital

  2016cites this paper
• New multi-component solid forms of anti-cancer drug Erlotinib: role of auxiliary interactions in determining a preferred conformation.

  2016cites this paper
• RPF151, a novel capsaicin-like analogue: in vitro studies and in vivo preclinical antitumor evaluation in a breast cancer model

  2015cites this paper
• Modularity and three-dimensional isostructurality of novel synthons in sulfonamide–lactam cocrystals

  2015cites this paper
• Cocrystals of Hydrochlorothiazide: Solubility and Diffusion/Permeability Enhancements through Drug-Coformer Interactions.

  2015cites this paper
• Aerosil as a novel co-crystal co-former for improving the dissolution rate of hydrochlorothiazide.

  2015cites this paper
• Improving solubility of fisetin by cocrystallization

  2014cites this paper
• Development, Characterization, and Pharmacodynamic Evaluation of Hydrochlorothiazide Loaded Self-Nanoemulsifying Drug Delivery Systems

  2014cites this paper
• Structural and physicochemical aspects of hydrochlorothiazide co-crystals

  2014cites this paper